Speaker(s):
Dr. Syeda Atiqa Batul- has nothing to disclose
Moderator(s):
Anil Singh, MD, Staff Member, Geisinger - has nothing to disclose.
Objectives:
Understand the epidemiology, pathophysiology and risk factors for sudden cardiac death (SCD).
Define the indications and limitations of wearable cardioverter defibrillators (WCDs).
Review the clinical evidence supporting the use of WCDs, patient selection criteria and consideration when prescribing WCDs.
Interactive case-based discussion of real-world scenarios with target audience to assess knowledge.
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Anil Kumar Singh, MD, Roop Parlapalli, MD, FHM, FACP, Lakshmi Rani Gollamudi, MD, Christopher DeFrancesco PharmD, RPH, Mary Ellen Berry, PA-C, and Carlena Miller, CRNP have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose.
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPAA compliant.
Commercial Support for this Session
None
- 1.00 AAPA Category I CME
- 1.00 ACPE
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation Credit

Facebook
X
LinkedIn
Forward